Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Praticien-chercheur
19 articles scientifiques publiés — formation continue solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
134 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CDS MUNICIPAL PIERRE ROUQUES
12-14 12 R DU GENERAL DE GAULLE, 94400 VITRY SUR SEINE
CMS HENRI DRET
10 R DES VIGNES, 94190 VILLENEUVE ST GEORGES
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Arthritis & rheumatology (Hoboken, N.J.) · 2019
ObjectiveTo estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome (APS).MethodsAn inception cohort of patients with incident APS in 2000–2015 from a geographically well‐defined population was identified based on comprehensive individual medical records review. All cases met the 2006 Sydney criteria for APS (primary definition) or had a diagnosis of APS confirmed by physician consensus (secondary definition). Levels of lupus anticoagulant, IgM and IgG anticardiolipin antibodies, and anti–β2‐glycoprotein I antibodies were tested in a centralized laboratory. Incidence rates were age‐ and sex‐adjusted to the 2010 US white population. Prevalence estimates were obtained from the incidence rates, assuming that there was no increased mortality associated with APS and that migration in or out of the area was independent of disease status.ResultsAmong this cohort in 2000–2015, 33 cases of incident APS, as defined by the Sydney criteria, were identified (mean age of patients 54.2 years; 55% female, 97% white). The annual incidence of APS in adults ages ≥18 years was 2.1 (95% confidence interval [95% CI] 1.4–2.8) per 100,000 population. Incidence rates were similar in both sexes. The estimated prevalence of APS was 50 (95% CI 42–58) per 100,000 population, and was similar in both sexes. Six patients (18%) had a concurrent diagnosis of systemic lupus erythematosus. The most frequent clinical manifestation was deep vein thrombosis. The overall frequency of mortality among patients with APS was not significantly different from that in the general population (standardized mortality ratio 1.61, 95% CI 0.74–3.05).ConclusionAPS occurred in ~2 persons per 100,000 population per year. The estimated prevalence was 50 per 100,000 population. Overall mortality was not notably different from that observed in the general population.
Trends in pharmacological sciences · 2025
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of clinical medicine · 2025 · Case Reports
Yaman R, DiCaudo DJ, Sokumbi O, Pham MM, et al.
Trends in pharmacological sciences · 2025 · Journal Article
Cabral JE, Wu A, Zhou H, Pham MA, et al.
Rheumatology international · 2025 · Journal Article
Guggenberger KV, Riedling L, Kern D, Werner RA, et al.
European radiology · 2023 · Multicenter Study
Guggenberger KV, Vogt ML, Song JW, Weng AM, et al.
Journal of thrombosis and haemostasis : JTH · 2022 · Journal Article
Pham M, Orsolini G, Crowson C, Snyder M, et al.
Osteoporosis and sarcopenia · 2020 · Journal Article
Nguyen HG, Pham MT, Ho-Pham LT, Nguyen TV
Frontiers in immunology · 2015 · Journal Article
Pham MN, von Herrath MG, Vela JL
Rheumatology (Oxford, England) · 2010 · Journal Article
Goebel JC, Bolbos R, Pham M, Galois L, et al.
International journal of surgery case reports · 2022 · Journal Article
Brown NJ, Shahrestani S, Kurtz JS, Beyer RS, et al.
The Pan African medical journal · 2020 · Case Reports
Vu DL, Thieu-Thi TM, Pham MT, Le-Thi M, et al.
Rheumatology (Oxford, England) · 2025 · Journal Article
Pham M, Bagaruka E, Oldham E, Chaudhry M, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2017 · Journal Article
Pham MH, Buser Z, Wang JC, Acosta FL
BMC musculoskeletal disorders · 2021 · Journal Article
Sullivan MM, Pham MM, Marks LA, Aslam F
Pain and therapy · 2025 · Journal Article
Ackermann L, Zeller D, Odorfer T, Homola GA, et al.
Rheumatology (Oxford, England) · 2025 · Journal Article
Guggenberger KV, Vogt ML, Song JW, Fröhlich M, et al.
Asian spine journal · 2017 · Journal Article
Stone MA, Jakoi AM, Iorio JA, Pham MH, et al.
Rheumatology (Oxford, England) · 2025 · Journal Article
Pham M, Bagaruka E, Oldham E, Chaudhry M, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2019 · Journal Article
Duarte-García A, Pham MM, Crowson CS, Amin S, et al.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2022 · Journal Article
Cumsky HJL, Pham MM, Hoss E
Clinical case reports · 2025 · Journal Article
Sahwan O, Jamal F, Elshaer A, Batha L, et al.